Skip to main content

Sarissa Consulting LLC

SEC CIK
0001915870
Latest filing
Nov 14, 2022

GBT holding history

Global Blood Therapeutics, Inc. in every 13F filed by Sarissa Consulting LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GBT overviewAll 13F holders of GBTFull Q3 2022 holdings

Shares (Q3 2022)
26,000
Value
$1.77M
% of portfolio
1.8%
Quarters held
1
Since Q3 2022
Holdings of GBT by Sarissa Consulting LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 202226,000$1.77M1.8%+26,000NewHolders